Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gaydos

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Beginnings (American Holistic Nurses' Association)|June 1, 1995
Announcing a new graduate program in holistic health nursing practiceL Gaydos
Alternative Therapies in Health and Medicine|July 10, 1998
Cheers for eloquent 'right man syndrome' editorialH L Gaydos
Nursing Management|May 1, 1997
Revitalizing nurses' week celebrationL Gaydos, K Baumgarten
Journal of Lower Genital Tract Disease|May 8, 2015
Dimethylether treatment for condyloma acuminata in womenT L Gaydos, H A Lambe, K Schwartz, et al.
Clinical Chemistry|October 1, 1995
Biochemical markers of bone turnover in patients with metastatic bone diseaseL M Demers, L Costa, V M Chinchilli, et al.
Diabetes Technology & Therapeutics|May 15, 2014
A clinical utility index for selecting an optimal insulin dosing algorithm for LY2605541 in patients with type 2 diabetes pretreated with basal insulinDavid H Manner, Junxiang Luo, Yongming Qu, et al.
Diabetes Care|July 22, 2016
Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering MedicationsByron J Hoogwerf, David H Manner, Haoda Fu, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Neuropsychological test performance in healthy volunteers before and after donepezil administrationLeigh J Beglinger, Brenda L Gaydos, David A Kareken, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Markers of bone resorption in patients treated with pamidronateA Lipton, L Demers, E Curley, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)Z Skrivanek, B L Gaydos, J Y Chien, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Beginnings (American Holistic Nurses' Association)|June 1, 1995
Announcing a new graduate program in holistic health nursing practiceL Gaydos
Alternative Therapies in Health and Medicine|July 10, 1998
Cheers for eloquent 'right man syndrome' editorialH L Gaydos
Nursing Management|May 1, 1997
Revitalizing nurses' week celebrationL Gaydos, K Baumgarten
Journal of Lower Genital Tract Disease|May 8, 2015
Dimethylether treatment for condyloma acuminata in womenT L Gaydos, H A Lambe, K Schwartz, et al.
Clinical Chemistry|October 1, 1995
Biochemical markers of bone turnover in patients with metastatic bone diseaseL M Demers, L Costa, V M Chinchilli, et al.
Diabetes Technology & Therapeutics|May 15, 2014
A clinical utility index for selecting an optimal insulin dosing algorithm for LY2605541 in patients with type 2 diabetes pretreated with basal insulinDavid H Manner, Junxiang Luo, Yongming Qu, et al.
Diabetes Care|July 22, 2016
Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering MedicationsByron J Hoogwerf, David H Manner, Haoda Fu, et al.
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Neuropsychological test performance in healthy volunteers before and after donepezil administrationLeigh J Beglinger, Brenda L Gaydos, David A Kareken, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Markers of bone resorption in patients treated with pamidronateA Lipton, L Demers, E Curley, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)Z Skrivanek, B L Gaydos, J Y Chien, et al.
Pageof 1